Correlation of CD4 count with Thyroid function test values in treatment naive HIV-infected patients.

##plugins.themes.academic_pro.article.main##

Jacquiline Dalbot Shira
Dr Abhijit Swami

Abstract

Introduction    Abnormalities in thyroid function tests have been described in HIV patients since the early days of the HIV pandemic. There have been only a handful of studies correlating the CD4 count with different aspects of commonly done thyroid function tests. Objective To study correlation between CD4 count and thyroid function tests in treatment naive HIV-infected patients. Methodology The current study was conducted on 100  (one hundred) treatment-naive newly diagnosed HIV patients without any co infections or therapy for any other disease, over one year. Results   64 % of the patients in the study group were euthyroid with subclinical hypothyroidism being the commonest thyroid abnormality. Thyroid dysfunction was commoner in the later stages of the disease. There was no statistical significance between CD4 count and Free T4 and Free T3 values; however low CD4 count had a negative correlation with TSH values in patients with overt primary hypothyroidism which was statistically significant only in the subgroup of patients with CD4 values < 200/µl (p<0.00001). Conclusion: Treatment naive HIV patients are mostly euthyroid but thyroid hypofunction is common in the advanced form of the disease with the subgroup of CD4 count <200/µl having higher TSH values of statistical significance in patients with overt primary hypothyroidism. This probably reflects an attempt by an intact pituitary-thyroid axis to maintain homeostasis in a severe immunodeficiency state with the production of active hormones in the thyroid gland being affected by multiple factors including infections, malignancies, and micronutrient deficiency.  


 

##plugins.themes.academic_pro.article.details##

How to Cite
Shira, J. D., & Swami, D. A. (2021). Correlation of CD4 count with Thyroid function test values in treatment naive HIV-infected patients. International Journal of Medical Science in Clinical Research and Review, 4(02), Page: 1–8. Retrieved from https://ijmscrr.in/index.php/ijmscrr/article/view/138

References

    1. Dobs, A. S., Dempsey, M. A., & Ladenson, P. W. (1988). Endocrine disorders in men infected with human immunodeficiency virus. Am J Med, (84), 611-618.
    2. Beltran, S., & Lescure, F. X. (2004). Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients with acquired immunodeficiency syndrome report of four cases. Journal of Microbiology, Immunology and Infection, (37), 250-253.
    3. Madeddu, G., Spanu, A., & Chessa, F. (2006). Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy. Clin Endocrinol (Oxf), 64, 375-383. doi:10.1111/j.1365-2265.2006.02472.x. PMID: 16584508.
    4. Beltran, S., Lescure, F. X., & Desailloud, R. (2003). Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening. Clin Infect Dis, 37, 579-583.
    5. Raffi, F., Brisseau, J., Planchon, B., Rémi, J., Barrier, J. H., & Grolleau, J. (1991). Endocrine function in 98 HIV-INFECTED patients. AIDS, 5(6), 729-734. doi:10.1097/00002030-199106000-00013
    6. Emokpae, M. A., & Akinnuoye, I. M. (2018). Asymptomatic thyroid dysfunction in human immunodeficiency virus-1-infected subjects. Journal of Laboratory Physicians, 10(02), 130-134. doi:10.4103/jlp.jlp_172_16
    7. Ji, S., Jin, C., Höxtermann, S., Fuchs, W., Xie, T., Lu, X., . . . Wu, N. (2016). Prevalence and influencing factors of thyroid dysfunction in hiv-infected patients. BioMed Research International, 2016, 1-11. doi:10.1155/2016/3874257.
    8. Midha, N. K., M., C., K., C. L., S., S., & M., G. (2017). Thyroid profile in newly Diagnosed male HIV patients: A study from North western part of India. International Journal of Research in Medical Sciences, 5(8), 3385-3388. doi:10.18203/2320-6012.ijrms20173527
    9. Noureldeen, A. F., Qusti, S. Y., & Khoja, G. M. (2012). Thyroid function in newly diagnosed hiv-infected patients. Toxicology and Industrial Health, 30(10), 919-925. doi:10.1177/0748233712466133
    10. Helfand, M. (2004). Screening for subclinical thyroid dysfunction in nonpregnant adults: A summary of the evidence for the u.s. preventive services task force. Annals of Internal Medicine, 140(2), 128. doi:10.7326/0003-4819-140-2-200401200-00015
    11. Madeddu, G., Spanu, A., Chessa, F., Calia, G. M., Lovigu, C., Solinas, P., . . . Madeddu, G. (2006). Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (haart): A longitudinal study. Clinical Endocrinology, 64(4), 375-383. doi:10.1111/j.1365-2265.2006.02472.x
    12. Lima, M. A., Freitas, L. L., Montandon, C., Filho, D. C., & Silva-Vergara, M. L. (1998). The thyroid in acquired immunodeficiency syndrome. Endocrine Pathology, 9(3), 217-223.
    13. Zavascki, A. P., Maia, A. L., & Goldani, L. Z. (2007). Pneumocystis jiroveci Thyroiditis: Report of 15 cases in the literature. Mycoses, 50(6), 443-446. doi:10.1111/j.1439-0507.2007.01395.x
    14. Hommes, M., Romijn, J., Endert, E., Adriaanse, R., Brabant, G., Eeftinck Schattenkerk, J., . . . Sauerwein, H. (1993). Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. Metabolism, 42(5), 556-561. doi:10.1016/0026-0495(93)90212-7
    15. Beltran, S., Lescure, F., El Esper, I., Schmit, J., & Desailloud, R. (2006). Subclinical hypothyroidism in hiv-infected patients is not an autoimmune disease. Hormone Research in Paediatrics, 66(1), 21-26. doi:10.1159/000093228
    16. Ricart-Engel, W., Fernández-Real, J. M., González-Huix, F., Del Pozo, M., Mascaró, J., & García-Bragado, F. (1996). The relation between thyroid function and nutritional status in hiv-infected patients. Clinical Endocrinology, 44(1), 53-58. doi:10.1046/j.1365-2265.1996.623445.x
    17. Contempré, B., Duale, N. L., Dumont, J. E., Ngo, B., Diplock, A. T., & Vanderpas, J. (1992). Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clinical Endocrinology, 36(6), 579-583. doi:10.1111/j.1365-2265.1992.tb02268.x
    18. Varghese, V., Menon, K. S., & Green, S. R. (2018). Effect of anti-tuberculosis treatment on thyroid profile in newly detected smear positive pulmonary tuberculosis cases. International Journal of Advances in Medicine, 5(3), 688-693. doi:10.18203/2349-3933.ijam20182124
    19. Ige, O. M., Akinlade, K. S., Rahamon, S. K., Edem, V. F., & Arinola, O. G. (2016). Thyroid function In multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen. African Health Sciences, 16(2), 596-602. doi:10.4314/ahs.v16i2.30
    20. Sellmeyer, D. E. (1996). Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocrine Reviews, 17(5), 518-532. doi:10.1210/er.17.5.518